PIN90 COMPARATIVE QUALITY OF LIFE OUTCOMES OF DOLUTEGRAVIR-BASED OR EFAVIRENZ-BASED ANTIRETOVIRAL TREATMENT IN PREGNANCY FOR LATE PRESENTORS BETWEEN THE 3RD TRIAL-MESTER AND 48 WEEKS POSTPARTUM
Abstract
Authors
O. Perez Nicholas M. Lamorde K. Kintu D. Wang T. Chen T. Malaba L. Myer C. Waitt H. Reynolds S. Khoo